{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:47:17Z","timestamp":1768686437505,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/136880\/2018"],"award-info":[{"award-number":["PD\/BD\/136880\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/97099\/2013"],"award-info":[{"award-number":["SFRH\/BD\/97099\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/92554\/2013"],"award-info":[{"award-number":["SFRH\/BPD\/92554\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/77900\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/77900\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECIND\/01463\/2017"],"award-info":[{"award-number":["CEECIND\/01463\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCOMP-01-0124-FEDER-027569"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-027569"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50017\/2020"],"award-info":[{"award-number":["UIDP\/50017\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50017\/2020"],"award-info":[{"award-number":["UIDB\/50017\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013239","name":"Centro de Estudos Ambientais e Marinhos, Universidade de Aveiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cluster Excellence Unifying Systems in Catalysis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11274-021-03196-y","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T02:02:22Z","timestamp":1641175342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-5687","authenticated-orcid":false,"given":"Joana C.","family":"Barbosa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-2757","authenticated-orcid":false,"given":"\u00cdtala C.","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-8761","authenticated-orcid":false,"given":"T\u00e2nia","family":"Caetano","sequence":"additional","affiliation":[]},{"given":"Eva","family":"M\u00f6sker","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-8230","authenticated-orcid":false,"given":"Maria","family":"Seidel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-6385","authenticated-orcid":false,"given":"Joana","family":"Louren\u00e7o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-2069","authenticated-orcid":false,"given":"Roderich D.","family":"S\u00fcssmuth","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0580-0475","authenticated-orcid":false,"given":"Nuno C.","family":"Santos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2903-4282","authenticated-orcid":false,"given":"S\u00f3nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-5660","authenticated-orcid":false,"given":"S\u00f3nia","family":"Mendo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"3196_CR1","doi-asserted-by":"publisher","first-page":"e83037","DOI":"10.1371\/journal.pone.0083037","volume":"8","author":"A Arguelles Arias","year":"2013","unstructured":"Arguelles Arias A, Ongena M, Devreese B et al (2013) Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1. PLoS ONE 8:e83037. https:\/\/doi.org\/10.1371\/journal.pone.0083037","journal-title":"PLoS ONE"},{"key":"3196_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/c2np20085f","volume":"30","author":"PG Arnison","year":"2013","unstructured":"Arnison PG, Bibb MJ, Bierbaum G et al (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108\u2013160. https:\/\/doi.org\/10.1039\/c2np20085f","journal-title":"Nat Prod Rep"},{"key":"3196_CR3","unstructured":"ATCC (2021) HFF-1|SCRC-1041TM. https:\/\/www.atcc.org\/products\/scrc-1041#documentation. Accessed 20 Oct 2020"},{"key":"3196_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1128\/AAC.01813-15","volume":"60","author":"P Baindara","year":"2016","unstructured":"Baindara P, Chaudhry V, Mittal G et al (2016) Characterization of the antimicrobial peptide penisin, a class Ia novel lantibiotic from Paenibacillus sp. Strain A3. Antimicrob Agents Chemother 60:580\u2013591. https:\/\/doi.org\/10.1128\/AAC.01813-15","journal-title":"Antimicrob Agents Chemother"},{"key":"3196_CR5","doi-asserted-by":"publisher","first-page":"17803","DOI":"10.1021\/jacs.7b04728","volume":"139","author":"A Bakhtiary","year":"2017","unstructured":"Bakhtiary A, Cochrane SA, Mercier P et al (2017) Insights into the mechanism of action of the two-peptide lantibiotic lacticin 3147. J Am Chem Soc 139:17803\u201317810. https:\/\/doi.org\/10.1021\/jacs.7b04728","journal-title":"J Am Chem Soc"},{"key":"3196_CR6","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1021\/np500424y","volume":"78","author":"J Barbosa","year":"2015","unstructured":"Barbosa J, Caetano T, Mendo S (2015) Class I and class II lanthipeptides produced by Bacillus spp. J Nat Prod 78:2850\u20132866. https:\/\/doi.org\/10.1021\/np500424y","journal-title":"J Nat Prod"},{"key":"3196_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/bit.27130","author":"J Barbosa","year":"2019","unstructured":"Barbosa J, Caetano T, Moesker E et al (2019) Lichenicidin rational site-directed mutagenesis library: a tool to generate bioengineered lantibiotics. Biotechnol Bioeng. https:\/\/doi.org\/10.1002\/bit.27130","journal-title":"Biotechnol Bioeng"},{"key":"3196_CR8","doi-asserted-by":"publisher","first-page":"31749","DOI":"10.1038\/srep31749","volume":"6","author":"A Barbour","year":"2016","unstructured":"Barbour A, Tagg J, Abou-Zied OK, Philip K (2016) New insights into the mode of action of the lantibiotic salivaricin B. Sci Rep 6:31749. https:\/\/doi.org\/10.1038\/srep31749","journal-title":"Sci Rep"},{"key":"3196_CR9","doi-asserted-by":"publisher","first-page":"e0187756","DOI":"10.1371\/journal.pone.0187756","volume":"12","author":"L Basmaciyan","year":"2017","unstructured":"Basmaciyan L, Azas N, Casanova M (2017) Calcein+\/PI- as an early apoptotic feature in Leishmania. PLoS ONE 12:e0187756. https:\/\/doi.org\/10.1371\/journal.pone.0187756","journal-title":"PLoS ONE"},{"key":"3196_CR10","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1128\/AEM.00730-09","volume":"75","author":"M Begley","year":"2009","unstructured":"Begley M, Cotter PD, Hill C, Ross RP (2009) Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol 75:5451\u20135460. https:\/\/doi.org\/10.1128\/AEM.00730-09","journal-title":"Appl Environ Microbiol"},{"key":"3196_CR11","doi-asserted-by":"publisher","first-page":"e00606","DOI":"10.1002\/mbo3.606","volume":"7","author":"T Bengtsson","year":"2018","unstructured":"Bengtsson T, L\u00f6nn J, Khalaf H, Palm E (2018) The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts. Microbiologyopen 7:e00606. https:\/\/doi.org\/10.1002\/mbo3.606","journal-title":"Microbiologyopen"},{"key":"3196_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.chembiol.2010.11.010","volume":"18","author":"T Caetano","year":"2011","unstructured":"Caetano T, Krawczyk JM, M\u00f6sker E et al (2011a) Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol 18:90\u2013100. https:\/\/doi.org\/10.1016\/j.chembiol.2010.11.010","journal-title":"Chem Biol"},{"key":"3196_CR13","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1128\/AEM.00270-11","volume":"77","author":"T Caetano","year":"2011","unstructured":"Caetano T, Krawczyk JM, M\u00f6sker E et al (2011b) Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection. Appl Environ Microbiol 77:5023\u20135026. https:\/\/doi.org\/10.1128\/AEM.00270-11","journal-title":"Appl Environ Microbiol"},{"key":"3196_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.resmic.2014.07.006","volume":"165","author":"T Caetano","year":"2014","unstructured":"Caetano T, Barbosa J, M\u00f6esker E et al (2014) Bioengineering of lanthipeptides in Escherichia coli: assessing the specificity of lichenicidin and haloduracin biosynthetic machinery. Res Microbiol 165:600\u2013604. https:\/\/doi.org\/10.1016\/j.resmic.2014.07.006","journal-title":"Res Microbiol"},{"issue":"6","key":"3196_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21385","volume":"61","author":"MH Cardoso","year":"2016","unstructured":"Cardoso MH, Ribeiro SM, Nolasco DO et al (2016) (2016) A polyalanine peptide derived from polar fish with anti-infectious activities. Sci Rep 61(6):1\u201315. https:\/\/doi.org\/10.1038\/srep21385","journal-title":"Sci Rep"},{"key":"3196_CR16","unstructured":"CLSI (2015) Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. CLSI Document M100-S25"},{"key":"3196_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1462-5822.2003.00310.x","volume":"5","author":"PS Coburn","year":"2003","unstructured":"Coburn PS, Gilmore MS (2003) The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 5:661\u2013669. https:\/\/doi.org\/10.1046\/j.1462-5822.2003.00310.x","journal-title":"Cell Microbiol"},{"key":"3196_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2958.2006.05398.x","volume":"62","author":"PD Cotter","year":"2006","unstructured":"Cotter PD, Deegan LH, Lawton EM et al (2006) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62:735\u2013747. https:\/\/doi.org\/10.1111\/j.1365-2958.2006.05398.x","journal-title":"Mol Microbiol"},{"key":"3196_CR19","doi-asserted-by":"publisher","first-page":"e6788","DOI":"10.1371\/journal.pone.0006788","volume":"4","author":"J Dischinger","year":"2009","unstructured":"Dischinger J, Josten M, Szekat C et al (2009) Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS ONE 4:e6788. https:\/\/doi.org\/10.1371\/journal.pone.0006788","journal-title":"PLoS ONE"},{"key":"3196_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijmm.2013.09.003","volume":"304","author":"J Dischinger","year":"2014","unstructured":"Dischinger J, Basi Chipalu S, Bierbaum G (2014) Lantibiotics: promising candidates for future applications in health care. Int J Med Microbiol 304:51\u201362. https:\/\/doi.org\/10.1016\/j.ijmm.2013.09.003","journal-title":"Int J Med Microbiol"},{"key":"3196_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2958.2008.06279.x","volume":"69","author":"D Field","year":"2008","unstructured":"Field D, Connor PMO, Cotter PD et al (2008) The generation of nisin variants with enhanced activity against specific Gram-positive pathogens. Mol Microbiol 69:218\u2013230. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06279.x","journal-title":"Mol Microbiol"},{"key":"3196_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.01363","volume":"6","author":"D Field","year":"2015","unstructured":"Field D, Cotter PD, Hill C, Ross RP (2015) Bioengineering lantibiotics for therapeutic success. Front Microbiol 6:1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2015.01363","journal-title":"Front Microbiol"},{"key":"3196_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/002215549804600804","volume":"46","author":"R Gatti","year":"1998","unstructured":"Gatti R, Belletti S, Orlandini G et al (1998) Comparison of annexin V and calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy. J Histochem Cytochem 46:895\u2013900. https:\/\/doi.org\/10.1177\/002215549804600804","journal-title":"J Histochem Cytochem"},{"key":"3196_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/303636","author":"F Godoy-Santos","year":"2018","unstructured":"Godoy-Santos F, Pitts B, Stewart PS, Mantovani HC (2018) Nisin penetrates Staphylococcus aureus biofilms but shows differences in killing effects against sessile and planktonic cells. Biorxiv. https:\/\/doi.org\/10.1101\/303636","journal-title":"Biorxiv"},{"key":"3196_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mib.2018.02.010","volume":"45","author":"GA Hudson","year":"2018","unstructured":"Hudson GA, Mitchell DA (2018) RiPP antibiotics: biosynthesis and engineering potential. Curr Opin Microbiol 45:61\u201369","journal-title":"Curr Opin Microbiol"},{"key":"3196_CR26","doi-asserted-by":"crossref","unstructured":"Hurst A (1981) Nisin. In: Advances in applied microbiology, pp 85\u2013123","DOI":"10.1016\/S0065-2164(08)70342-3"},{"key":"3196_CR27","unstructured":"Invitrogen (2020) LIVE\/DEAD\u00ae Viability\/Cytotoxicity Kit for mammalian cells. \/\/www.thermofisher.com\/uk\/en\/home\/references\/protocols\/cell-and-tissue-analysis\/protocols\/live-dead-viability-cytotoxicity-kit-for-mammalian-cells.html. Accessed 20 Oct 2020"},{"key":"3196_CR28","doi-asserted-by":"publisher","DOI":"10.1042\/BST20120190","author":"MR Islam","year":"2012","unstructured":"Islam MR, Nagao J-I, Zendo T, Sonomoto K (2012) Antimicrobial mechanism of lantibiotics. Biochem Soc Trans. https:\/\/doi.org\/10.1042\/BST20120190","journal-title":"Biochem Soc Trans"},{"key":"3196_CR29","unstructured":"ISO (2006) ISO 20776-1:2006\u2014Clinical laboratory testing and in vitro diagnostic test systems\u2014Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices\u2014Part 1: reference method for testing the i"},{"key":"3196_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/J.IJANTIMICAG.2019.03.020","volume":"53","author":"M Jangra","year":"2019","unstructured":"Jangra M, Kaur M, Nandanwar H (2019) In vitro studies on a natural lantibiotic, paenibacillin: a new-generation antibacterial drug candidate to overcome multi-drug resistance. Int J Antimicrob Agents 53:838\u2013843. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2019.03.020","journal-title":"Int J Antimicrob Agents"},{"key":"3196_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/FFT2.44","volume":"1","author":"S Kamiloglu","year":"2020","unstructured":"Kamiloglu S, Sari G, Ozdal T, Capanoglu E (2020) Guidelines for cell viability assays. Food Front 1:332\u2013349. https:\/\/doi.org\/10.1002\/FFT2.44","journal-title":"Food Front"},{"key":"3196_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fmicb.2018.00415","volume":"9","author":"JA Kers","year":"2018","unstructured":"Kers JA, Sharp RE, Defusco AW et al (2018) Mutacin 1140 lantibiotic variants are efficacious against Clostridium difficile Infection. Front Microbiol 9:415. https:\/\/doi.org\/10.3389\/fmicb.2018.00415","journal-title":"Front Microbiol"},{"key":"3196_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-biochem-060110-113521","volume":"81","author":"PJ Knerr","year":"2012","unstructured":"Knerr PJ, van der Donk WA (2012) Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 81:479\u2013505. https:\/\/doi.org\/10.1146\/annurev-biochem-060110-113521","journal-title":"Annu Rev Biochem"},{"key":"3196_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-015-6557-6","author":"A Kuthning","year":"2015","unstructured":"Kuthning A, M\u00f6sker E, S\u00fcssmuth RD (2015) Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly. Appl Microbiol Biotechnol. https:\/\/doi.org\/10.1007\/s00253-015-6557-6","journal-title":"Appl Microbiol Biotechnol"},{"key":"3196_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(47)90004-4","volume":"37","author":"ATR Mattick","year":"1947","unstructured":"Mattick ATR, Hirsch A (1947) Further observations on an inhibitory substance (nisin) from lactic Streptococci. The Lancet 37:320\u2013408. https:\/\/doi.org\/10.1016\/S0140-6736(47)90004-4","journal-title":"The Lancet"},{"key":"3196_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/anie.200905773","volume":"49","author":"K Meindl","year":"2010","unstructured":"Meindl K, Schmiederer T, Schneider K et al (2010) Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed 49:1151\u20131154. https:\/\/doi.org\/10.1002\/anie.200905773","journal-title":"Angew Chem Int Ed"},{"key":"3196_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/B:BILE.0000012888.72489.3f","volume":"26","author":"S Mendo","year":"2004","unstructured":"Mendo S, Faustino NA, Sarmento AC et al (2004) Purification and characterization of a new peptide antibiotic produced by a thermotolerant Bacillus licheniformis strain. Biotechnol Lett 26:115\u2013119. https:\/\/doi.org\/10.1023\/B:BILE.0000012888.72489.3f","journal-title":"Biotechnol Lett"},{"key":"3196_CR38","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1002\/anie.201500927","volume":"54","author":"KI Mohr","year":"2015","unstructured":"Mohr KI, Volz C, Jansen R et al (2015) Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed 54:11254\u201311258. https:\/\/doi.org\/10.1002\/anie.201500927","journal-title":"Angew Chem Int Ed"},{"key":"3196_CR39","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/AAC.49.7.2606-2611.2005","volume":"49","author":"SM Morgan","year":"2005","unstructured":"Morgan SM, O\u2019Connor PM, Cotter PD et al (2005) Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother 49:2606\u20132611. https:\/\/doi.org\/10.1128\/AAC.49.7.2606-2611.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"3196_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/anie.201106154","volume":"51","author":"F Oldach","year":"2012","unstructured":"Oldach F, Al Toma R, Kuthning A et al (2012) Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew Chem 51:415\u2013418. https:\/\/doi.org\/10.1002\/anie.201106154","journal-title":"Angew Chem"},{"key":"3196_CR41","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1021\/cb900194x","volume":"4","author":"TJ Oman","year":"2009","unstructured":"Oman TJ, van der Donk WA (2009) Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem Biol 4:865\u2013874. https:\/\/doi.org\/10.1021\/cb900194x","journal-title":"ACS Chem Biol"},{"key":"3196_CR42","doi-asserted-by":"publisher","first-page":"17544","DOI":"10.1021\/ja206281k","volume":"133","author":"TJ Oman","year":"2011","unstructured":"Oman TJ, Lupoli TJ, Wang T-SA et al (2011) Haloduracin \u03b1 binds the peptidoglycan precursor lipid II with 2:1 stoichiometry. J Am Chem Soc 133:17544\u201317547. https:\/\/doi.org\/10.1021\/ja206281k","journal-title":"J Am Chem Soc"},{"key":"3196_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12934-016-0502-y","volume":"15","author":"EL Ongey","year":"2016","unstructured":"Ongey EL, Neubauer P (2016) Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production. Microb Cell Fact 15:97. https:\/\/doi.org\/10.1186\/s12934-016-0502-y","journal-title":"Microb Cell Fact"},{"key":"3196_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/cbf.3135","volume":"33","author":"M Pagano","year":"2015","unstructured":"Pagano M, Faggio C (2015) The use of erythrocyte fragility to assess xenobiotic cytotoxicity. Cell Biochem Funct 33:351\u2013355. https:\/\/doi.org\/10.1002\/cbf.3135","journal-title":"Cell Biochem Funct"},{"key":"3196_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1590\/S1413-86702008000200003","volume":"12","author":"PFR Palma","year":"2008","unstructured":"Palma PFR, Baggio GL, Spada C et al (2008) Evaluation of annexin V and calcein-AM as markers of mononuclear cell apoptosis during human immunodeficiency virus infection. Braz J Infect Dis 12:108\u2013114. https:\/\/doi.org\/10.1590\/S1413-86702008000200003","journal-title":"Braz J Infect Dis"},{"key":"3196_CR46","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1074\/jbc.RA117.000125","volume":"293","author":"C P\u00e9rez-Peinado","year":"2018","unstructured":"P\u00e9rez-Peinado C, Dias SA, Domingues MM et al (2018) Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15\u201334), antimicrobial peptides from rattlesnake venom. J Biol Chem 293:1536\u20131549. https:\/\/doi.org\/10.1074\/jbc.RA117.000125","journal-title":"J Biol Chem"},{"key":"3196_CR47","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.3390\/md10102280","volume":"10","author":"ML Prieto","year":"2012","unstructured":"Prieto ML, O\u2019Sullivan L, Tan SP et al (2012) Assessment of the bacteriocinogenic potential of marine bacteria reveals lichenicidin production by seaweed-derived Bacillus spp. Mar Drugs 10:2280\u20132299. https:\/\/doi.org\/10.3390\/md10102280","journal-title":"Mar Drugs"},{"key":"3196_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/rep.1.00028","volume":"128","author":"KVR Reddy","year":"2004","unstructured":"Reddy KVR, Aranha C, Gupta SM, Yedery RD (2004) Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 128:117\u2013126. https:\/\/doi.org\/10.1530\/rep.1.00028","journal-title":"Reproduction"},{"key":"3196_CR49","doi-asserted-by":"publisher","first-page":"7780","DOI":"10.1038\/s41598-018-26238-2","volume":"8","author":"Y Ren","year":"2018","unstructured":"Ren Y, Ma Z, Yu T et al (2018) Methanol fixed fibroblasts serve as feeder cells to maintain stem cells in the pluripotent state in vitro. Sci Rep 8:7780. https:\/\/doi.org\/10.1038\/s41598-018-26238-2","journal-title":"Sci Rep"},{"key":"3196_CR50","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1021\/acs.chemrev.6b00591","volume":"117","author":"LM Repka","year":"2017","unstructured":"Repka LM, Chekan JR, Nair SK, van der Donk WA (2017) Mechanistic understanding of lanthipeptide biosynthetic enzymes. Chem Rev 117:5457\u20135520. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00591","journal-title":"Chem Rev"},{"key":"3196_CR51","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1021\/bi100871b","volume":"49","author":"ZO Shenkarev","year":"2010","unstructured":"Shenkarev ZO, Finkina EI, Nurmukhamedova EK et al (2010) Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry 49:6462\u20136472. https:\/\/doi.org\/10.1021\/bi100871b","journal-title":"Biochemistry"},{"key":"3196_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ja.2011.5","volume":"64","author":"F Silva","year":"2011","unstructured":"Silva F, Louren\u00e7o O, Queiroz JA, Domingues FC (2011) Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye. J Antibiot 64:321\u2013325. https:\/\/doi.org\/10.1038\/ja.2011.5","journal-title":"J Antibiot"},{"key":"3196_CR53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/17425255.2011.573478","volume":"7","author":"AJ van Heel","year":"2011","unstructured":"van Heel AJ, Montalban-Lopez M, Kuipers OP (2011) Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opin Drug Metab Toxicol 7:675\u2013680. https:\/\/doi.org\/10.1517\/17425255.2011.573478","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3196_CR54","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/toxins5050895","volume":"5","author":"D Van Tyne","year":"2013","unstructured":"Van Tyne D, Martin MJ, Gilmore MS (2013) Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins 5:895\u2013911. https:\/\/doi.org\/10.3390\/toxins5050895","journal-title":"Toxins"},{"key":"3196_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2958.2006.05223.x","volume":"61","author":"I Wiedemann","year":"2006","unstructured":"Wiedemann I, B\u00f6ttiger T, Bonelli RR et al (2006) The mode of action of the lantibiotic lacticin 3147\u2014a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61:285\u2013296. https:\/\/doi.org\/10.1111\/j.1365-2958.2006.05223.x","journal-title":"Mol Microbiol"},{"key":"3196_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.micro.61.080706.093501","volume":"61","author":"JM Willey","year":"2007","unstructured":"Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61:477\u2013501. https:\/\/doi.org\/10.1146\/annurev.micro.61.080706.093501","journal-title":"Annu Rev Microbiol"},{"key":"3196_CR57","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1128\/AEM.01851-15","volume":"81","author":"B Xin","year":"2015","unstructured":"Xin B, Zheng J, Xu Z et al (2015) Three novel lantibiotics, ticins A1, A3, and A4, have extremely stable properties and are promising food biopreservatives. Appl Environ Microbiol 81:6964\u20136972. https:\/\/doi.org\/10.1128\/AEM.01851-15","journal-title":"Appl Environ Microbiol"},{"key":"3196_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2016.01115","author":"B Xin","year":"2016","unstructured":"Xin B, Zheng J, Liu H et al (2016) Thusin, a novel two-component lantibiotic with potent antimicrobial activity against several gram-positive pathogens. Front Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2016.01115","journal-title":"Front Microbiol"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-021-03196-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T08:13:55Z","timestamp":1641888835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-021-03196-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1007\/s11274-021-03196-y","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Blood from healthy blood donors was obtained with their previous written informed consent, following a protocol with the Portuguese Blood Institute (Lisbon, Portugal), approved by the joint Ethics Committee of Faculdade de Medicina da Universidade de Lisboa and Centro Hospitalar Lisboa Norte (Lisbon, Portugal).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"18"}}